Pulmatrix, Inc.
🏢 View company profile →9Patents
9Active
9Granted
49Portfolio score
Filing activity: Mar 6, 2007 → May 20, 2015 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9061352B2 | Dry powder formulations and methods for treating pulmonary diseases | Human Necessities | 15 | Active |
| US8187637B2 | Formulations decreasing particle exhalation | Human Necessities | 14 | Active |
| US8758824B2 | Respirably dry powder comprising calcium lactate, sodium chloride and leucine | Emerging Cross-Sectional Technologies | 13 | Active |
| US8591866B2 | Formulations decreasing particle exhalation | Human Necessities | 10 | Active |
| US8992983B2 | Respirably dry powder comprising calcium lactate, sodium chloride and leucine | Emerging Cross-Sectional Technologies | 6 | Active |
| US9233158B2 | Dry powder formulations and methods for treating pulmonary diseases | Human Necessities | 6 | Active |
| US8627821B2 | Method and device for decreasing contamination | Physics | 6 | Active |
| US9433576B2 | Cationic dry powders | Human Necessities | 3 | Active |
| US9642798B2 | Monovalent metal cation dry powders for inhalation | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.